Huber Martin H. Jr. is President, CEO of Mersana Therapeutics Inc.
Person profile
Roles
Mersana Therapeutics
President, CEO
Xilio Therapeutics
Officer
Address
Waltham, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Syndax Pharmaceuticals Inc
9 Feb 24
4
Mersana Therapeutics, Inc.
17 Jan 24
4
Mersana Therapeutics, Inc.
4 Oct 23
4
Mersana Therapeutics, Inc.
13 Sep 23
4
Xilio Therapeutics, Inc.
18 Aug 23
4
Mersana Therapeutics, Inc.
6 Jul 23
4
Mersana Therapeutics, Inc.
12 Jun 23
4
Mersana Therapeutics, Inc.
5 Apr 23
4
Syndax Pharmaceuticals Inc
3 Feb 23
4
Xilio Therapeutics, Inc.
4 Jan 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jan 24 | MRSN Mersana Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 44,250 | 0.00 | 44,250 |
15 Jan 24 | MRSN Mersana Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.02 | 199,125 | 601.36 k | 199,125 |
2 Oct 23 | MRSN Mersana Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 9,102 | 11.47 k | 9,102 |
11 Sep 23 | MRSN Mersana Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 667,000 | 0.00 | 667,000 |
11 Sep 23 | MRSN Mersana Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 1.32 | 1,000,000 | 1.32 mm | 1,000,000 |
16 Aug 23 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.785 | 136,500 | 380.15 k | 136,500 |
8 Jun 23 | MRSN Mersana Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 14,467 | 0.00 | 14,467 |
8 Jun 23 | MRSN Mersana Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 8.64 | 18,355 | 158.59 k | 18,355 |